Pharmos is actively seeking partnership opportunities to expedite development and commercialization of our pipeline assets and to share the risks inherent in drug development. We are interested in entering into alliances with corporate partners under a variety of potential forms, including out-licensing and co-development arrangements. Pharmos is also pursuing partnering opportunities in which we may broaden and enhance our product pipeline by in-licensing compounds in development for indications consistent with our therapeutic focus on disorders of the nervous system including the brain-gut axis (gastrointestinal/irritable bowel syndrome), pain/inflammation and autoimmune disorders.
To learn more about partnering opportunities with Pharmos, please contact us at Business.development@pharmos.com.
